An association between a genetically determined deficiency of the serum enzyme al antitrypsin and pulmonary emphysema is now well established. Serum antitryptic activity was measured in 103 patients suspected of having emphysema. Eighty-seven fulfilled the diagnostic criteria for emphysema and, of these, 16 had deficient levels, 5 had intermediate levels, and 66 had normal levels. The results of clinical, radiographic, and physiological studies in each group were then compared. Characteristic features noted in the deficient group included onset of dyspnoea during the third or fourth decades and uniformly symmetrical radiographic lower zone involvement. Other factors such as sex distribution, cigarette smoking, and chronic bronchitis are discussed.
Emphysema is most commonly diagnosed in men with chronic bronchitis in the fifth or sixth decades (Talamo, Blennerhassett, and Austen, 1966) . Cigarette smoking and recurrent pulmonary infection have been suggested as important aetiological factors, but although the occurrence of emphysema in families has been recognized since the early nineteenth century (Louis, 1837) there has, until recently, been little direct evidence about genetic factors. Laurell and Eriksson in 1963 and Eriksson in 1965 first described an association between chronic obstructive pulmonary disease and a genetically determined deficiency of a1 antitrypsin, the chief component of a1 globulin. Family studies revealed a trimodal distribution of a, antitrypsin serum levels with normal, intermediate (approximately 60% of normal), and deficient (less than 15% of normal) levels, compatible with the hypothesis of an autosomal recessive mode of inheritance. The homozygotes for the deficiency gene were found to have a high incidence of emphysema, while the heterozygotes, classed as those with intermediate levels, did not show this association. These findings have since been confirmed both in the United States and in Europe, though the exact role of the heterozygous state is undecided.
This paper presents the findings in a selected series of patients attending the Brompton Hospital with chronic respiratory disease in whom levels of serum antitryptic activity were estimated.
DIAGNOSIS OF EMPHYSEMA
Emphysema is defined on an anatomical basis as a disease characterized by structural changes in the lung causing increase, beyond the normal range, in the size of air spaces distal to terminal bronchioles (Scadding, 1969) . In life, however, histopathological specimens are not usually available and therefore the diagnosis depends on clinical, radiological, and physiological criteria. For the purpose of this study the following radiological and physiological criteria were adopted, the former having been shown to be strongly correlated with moderate to severe emphysema (Reid and Millard, 1964 ): 1. Radiological (Simon, 1964) . lung capacity (TLC), and RV/TLC% (>45%) (c) Impaired gas transfer (TLco).
DIAGNOSIS OF CHRONIC BRONCHTIS
Simple chronic bronchitis is defined as a chronic or recurrent increase in the volume of mucoid bronchial secretion sufficient to cause expectoration (Lancet, 1965) . For the purpose of this study the diagnosis was applied to any patient who had coughed up sputum on most days during at least three consecutive months for more than two successive years.
MATERLAL
Serum antitryptic activity was measured in the following:
coNRmOLs Eighty-seven subjects consisting of 39 healthy blood donors, 35 members of the hospital staff, and 13 patients who had non-respiratory disease. (Mancini, Vaerman, Carbonara, and Hermans, 1964) using rabbit anti-al antitrypsin antiserum (Behringwerke).
PATIENTS
The following criteria were adopted: Deficient < 100 mg% Intermediate 100-200 mg% Normal > 200 mg% CLINICAL The following investigations were performed on all patients with emphysema: (a) Postero-anterior and lateral chest radiographs. Tomography was used in some cases for the identification of bullae and the study of blood vesset distribution.
(b) Detailed pulmonary function tests including static lung volumes, spirometry (before and after bronchodilator aerosol), and gas transfer factor (TLco). The latter was measured by the steady state method (MacNamara, Prime, and Sinclair, 1959) or, in a few cases, by the single breath technique (Ogilvie, Forster, Blakemore, and Morton, 1957) . Approximately half the patients also had arterial blood gas estimations and regional lung function studies using xenon 133 (Mannell, Prime, and Smith, 1966) .
RESULTS
LABORATORY RESULTS (Table I and Patients Sixteen patients without emphysema all had T.I.C. levels of 0.85 mg/ml or above. Eighty-seven patients with emphysema were divided according to their T.I.C. levels:
(a) Deficient group: sixteen patients came into this category with levels between 0.12 and 0.33 mg/ml (mean 0.32 mg/ml; S.D.+0.03). All had a greatly diminished or absent a, globulin zone on electrophoresis.
(b) Intermediate group: five patients had T.I.C. levels ranging from 0.61 to 0.79 mg/ml (mean 0.72 + 0.06). These showed a diminished a, globulin zone on electrophoresis.
(c) Non-deficient group: the remaining 66 patients had levels between 0.81 and 1.94 mg/ml (mean 1.25 mg/ml +0.30) with normal electrophoretic strips.
Relatives of patients in deficient group (Table II) Sixty-eight relatives consisted of 9 parents, 9 spouses, 15 siblings, and 35 children. The latter included 21 children of index cases plus 6 children of two siblings also found to be a1 antitrypsin deficient and 8 children of two other siblings with intermediate T.I.C. levels.
Assuming from previous evidence (Eriksson, 1965) transmitted as an autosomal recessive, the nine parents and 27 of the children examined may be regarded as 'genetic heterozygotes' unless any of the spouses of index cases also 'carry' the gene when some of the children might then be deficient homozygotes. In fact two children of case 4 had T.I.C. levels of 0.25 mg/ml and 0.35 mg/ml respectively, indicating that the spouse was probably a heterozygote despite a T.I.C. level of 0.82 mg/ml. The T.I.C. levels in the remaining 34 subjects ranged from 0.49 to 0.87 mg/ml with a mean of 0.73 mg/ml (S.D.+0.115). (One parent with a level of 1.00 mg/ml was excluded because he was receiving oestrogen therapy.) Eight of the 34 genetic heterozygotes had levels between 0.80 and 0.87 mg/ml (included in a separate column in Table II ) but in four of these a1 antitrypsin levels were estimated and found to be less than 200 mg% (105 mg%, 180 mg%, 180 mg%, and 195 mg%).
Among the eight remaining children three had intermediate and five non-deficient T.I.C. levels. One of the latter had a level of 0.82 mg/ml, but an a1 antitrypsin level of 110 mg% (intermediate).
Of the 15 siblings, four had deficient, five intermediate, and six non-deficient levels. Two of the six non-deficient siblings had T.I.C. levels of 0.87 and 0.89 mg/ml. Both, however, had a1 antitrypsin levels of 170 mg% (intermediate range).
If these two siblings are regarded as heterozygotes, the findings became compatible with a recessive mode of inheritance with four deficient homozygotes, seven heterozygotes, and four normal subjects corresponding to the predicted ratio of 1:2:1.
The nine spouses all had non-deficient T.I.C. levels.
Thirty-nine relatives had both T.I.C. and a, antitrypsin levels estimated. A good degree of correlation was found in 32 subjects, 3 with deficient, 15 with intermediate, and 14 with nondeficient levels recorded by each method. In the (Table III) There were 76 male and 11 female patients (ratio 7:1). This ratio was the same in both the deficient (14 males and 2 females) and non-deficient (57 males and 9 females) groups. All five patients with intermediate levels were males.
Age (Table III He did not develop dyspnoea until the age of 49 years, over 13 years above the mean age and 7 years later than any other patient in that group. There were 11 non-smokers (7 male and 4 female) in the non-deficient group and none in the intermediate group.
Chronic bronchitis (Table III) Sixty-eight of the 87 patients with emphysema had chronic bronchitis and all were cigarette smokers. In the deficient group 12 (75%) had chronic bronchitis, symptoms of cough and sputum preceding dyspnoea in some cases. Excepting the nonsmoker in this group, there was no difference in the age at onset of dyspnoea or presentation between those with and those without cAronic bronchitis.
Peptic ulcer (Table III) Evidence of peptic ulceration, based on recent or previous barium studies, was obtained in 12 (13.7%) of all 87 patients, none being in the deficient group.
Radiographic findings (Table V and Fig. 2) In the deficient group the radiographic features of emphysema were marked. The distribution in every case was symmetrical, involving predominantly the lower zones. Bullae were seen in six (37.5%), always in the iower zones. In the other groups the appearances were more variable, symmetry was less evident, and upper zone involvement was common. Bullae were present in 29 (40.8%). Fig. 3 ), the other with a normal T.I.C. level. The remaining 47 relatives were free from respiratory disease. Haupt (1962) , its physical characteristics are now well described (Schultze et al., 1963) . It is responsible for approximately 90% of the total serum T.I.C., the remaining 10% being mainly in the form of an a2 macroglobulin. The role of a1 antitrypsin in healthy subjects is as yet unknown. Raised levels have been reported in association with malignant disease (Clark, Clifton, and Newton, 1948) , pregnancy (Faarvang and ibIs Lauritsen, 1963) , and in response to a variety of stimuli including infections (Jacobsson, 1955) , typhoid vaccine (Kueppers, 1968) , oestrogens (Schumacher and Pearl, 1968) , surgical stress, and corticosteroids (Faarvang and Lauritsen, 1963) . This study has confirmed the association between a genetically determined deficiency of a, antitrypsin and pulmonary emphysema. Sixteen (18.4%) of the 87 patients with clinical, radiological, and physiological evidence of emphysema had absent a, globulin fractions on serum electrophoresis and unequivocally deficient T.I.C. levels of 0.33 mg/ml or less, 11 to 30% of the mean level in controls. This incidence of 18.4% in a highly selected group of patients is greater than that found in other series. However, methods of selection and investigation have differed widely, making comparisons difficult. The previous highest incidence was 11 % of 55 individuals with severe airways obstruction reported by Pedersen, Weeke, and Georg (1969) whose criteria most closely matched those of this study. It is probable, as these authors implied, that the more stringent the criteria used the higher the incidence obtained is likely to be, an observation that would apply particularly to this study. Local environmental factors cannot be implicated as the patients came from many different geographical areas both urban and rural. The clinical picture of emphysema in patients with a1 antitrypsin deficiency is well documented (Talamo, Blennerhassett, and Austen, 1966) and shows certain features not seen with emphysema in general. The most consistent difference is the much earlier age at which dyspnoea develops, usually in the third decade. The youngest recorded case is 22 years (Makino, Chosy, Valdivia, and Reed, 1970) . In the present series the mean age at onset of dyspnoea was only 35 years; four-fifths of the patients in the deficient group were dyspnoeic before the age of 40 years and all before the age of 50 years. Considering all 87 emphysema patients, the younger the age at which symptoms developed, the higher was the incidence of a1 antitrypsin deficiency: among the 20 patients who became dyspnoeic before the age of 40 years, 60% were a1 antitrypsin deficient.
Similar observations were made in the six relatives also found to be a1 antitrypsin deficient. Three, aged 38 to 49 years, had undoubted emphysema while the other three, all under 35 years of age, were symptom-free though not fully investigated. Recent evidence (Levine, Talamo, Shannon, and Kazemi, 1970) suggests that detailed physiological evaluation of lung function may detect abnormalities in asymptomatic patients with a1 antitrypsin deficiency and that altered distribution of pulmonary perfusion using xenon 133 is the earliest detectable defect. Thus, it appears that the majority of subjects with a1 antitrypsin deficiency, approximately 90% according to Eriksson (1965) , are likely to develop emphysema before the age of 50 years. Kowalyshyn and Sataline (1969) stated that emphysema associated with a1 antitrypsin deficiency occurs predominantly in females, but this has not been confirmed in most series.
Although 10 of 13 a1 antitrypsin deficient patients with emphysema reported by Welch, Reinecke, Hammersten, and Guenter (1969) were women, these authors commented that this might not be a true representation of sex distribution, as young women with emphysema were sufficiently unusual to prompt referral for consultation. In the present series a great excess of men was found among deficient and non-deficient emphysema patients, the sex ratio being 7: 1 in both groups. Eriksson (1965) found emphysema in 88% of men with a1 antitrypsin deficiency but in only 50% of women. This suggests that either a1 antitrypsin deficient females are protected against the development of emphysema or that exogenous factors, affecting men predominantly, are important.
The importance of cigarette smoking to the early development of symptoms in patients with emphysema and a1 antitrypsin deficiency has been emphasized (Kueppers, Fallat, and Larson, 1969 ).
This may have been relevant in the case mentioned by Townley, Ryning, Lynch, and Brody (1970) ; this was a 46-year-old male nonsmoker who, though a deficient homozygote, showed no evidence of emphysema. In the present study the mean age at onset of dyspnoea in the deficient group was 35.6 years, yet symptoms did not develop until the age of 49 years in the only non-smoker in the group. Among non-deficient patients no such difference between smokers and non-smokers was apparent.
It has been reported (Talamo, Allen, Kahan, and Austen, 1968 ) that chronic bronchitis occurs infrequently in association with emphysema in a1 antitrypsin deficient subjects. However, a review of the literature shows that the majority of patients do have the features of chronic bronchitis, though clinical details are often sparse and evaluation difficult. Sixteen (70%) of Eriksson's (1965) 23 patients had produced sputum for five years or more while 10 (77 %1) of 13 patients reported by Welch et al. (1969) were said to have bronchitis. In the present study 75% of the ca1 antitrypsin deficient patients and 78 % of all patients gave a history of chronic bronchitis.
It is of interest to note that a history of extrinsic allergic asthma, a disease in which genetic factors are probably important, was found in case 5 and in one of his sons who was a heterozygote. A similar family history of extrinsic allergic asthma was recorded in two of Eriksson's deficient homozygotes (1965) and in four members of the family reported by Townley et al. (1970) .
A high incidence of peptic ulcer has been reported in patients with a variety of chronic bronchopulmonary diseases (Mitchell and Filley, 1964) . Eriksson (1965) found an incidence of 30% in deficient homozygotes with emphysema and -similar results have since been obtained (Lieberman, 1969) . By comparison, in this study, though 15% of non-deficient patients gave a history of peptic ulcer none of the deficient group did so.
The radiographic appearances of emphysema in a1 antitrypsin deficient patients have been described in detail (Welch et al., 1969) and agree closely with those seen here. Involvement was invariably symmetrical and maximal in the lower zones. Bullae were common. These changes differed from those seen in non al antitrypsin deficient patients in whom symmetry was infrequent and upper zone distribution common.
However, a clear-cut distinction was not always apparent; 19 (28.8%) of the non-deficient group -of patients also exhibited lower zone predomin-.ance. Nevertheless, it is evident that a1 antitrypsin deficiency should be suspected in patients presenting before the age of 50 years with progressive *dyspnoea and radiographic evidence of symmetrical lower zone emphysema.
Radioxenon studies confirmed the impairment of ventilation and perfusion to the lower zones in the a1 antitrypsin deficient group of patients. Other tests of pulmonary function differed little between the three groups.
Whereas the homozygous deficient state was readily identified on the basis of T.I.C. levels alone, using Eriksson's criteria, no such precise correlation existed between the heterozygous state and intermediate T.I.C. levels. Family studies indicated that several 'genetic heterozygotes' had T.I.C. levels of between 0.8 and 0.87 mg/ml. Lieberman (1969) and Kueppers (1967) , using similar techniques, have also recorded T.I.C. levels of 0.85 mg/ml or greater in true heterozygotes. It has been shown that heterozygotes, unlike deficient homozygotes, are capable of increasing their T.I.C. levels to within the normal range in response to certain stimuli (Kueppers, 1968) . This was probably the case in the male parent of the homozygous patient who had a T.I.C. level of 1.00 mg/ml and who was being treated with oestrogens for carcinoma of the prostate.
In view of the possible overlap in T.I.C. levels in a proportion of heterozygotes and normal subjects, accurate distinction between the two is difficult and leads to an underestimate of the frequency of the heterozygous state. Eriksson (1965) found a frequency of 4.7% in a Scandinavian population and Kueppers, Briscoe, and Bearns (1964) 2.1 % in a small white population in Georgia, U.S.A. Using similar techniques in the present study, we found that 10% of controls had intermediate T.I.C. levels, the number rising to 14% if the upper limit is raised to 0.9 mg/ml. Kueppers, Fallat, and Larson (1969) , in a followup study using 'antigen antibody crossed electrophoresis', a technique based on qualitative rather than quantitative differences in globulins which, they claim, distinguishes reliably between heterozygotes and normal individuals, found an incidence of 9 to 14% of heterozygotes in their controls.
Due partly to the difficulties in recognizing the heterozygous state, its role in the development of pulmonary disease has remained in dispute.
Eriksson (1965) and other workers failed to find any evidence to associate the heterozygous state with lung disease in general or emphysema in particular. However, using antigen antibody crossed electrophoresis, Kueppers et al. (1969) found that 25.5% of their patients with 'obstructive lung disease' compared to 9 to 14% of their controls were heterozygotes whereas, when T.I.C. estimations alone had been used in an earlier series, they had found no heterozygotes among 99 patients with emphysema. Lieberman (1969) measured the T.I.C. levels of 66 patients with emphysema and found 15.2 % of heterozygotes and 10.6% of deficient homozygotes. These authors did not have a control group but regarded a T.I.C. level of 0.85 mg/ml as the upper limit of normal.
Unfortunately, assessment of these findings is complicated by the fact that the terms emphysema and particularly chronic obstructive lung disease, so commonly used, are often not precisely defined. In the present series there was no evident association between the heterozygous state and either chronic bronchitis or emphysema.
The relationship between a1 antitrypsin deficiency and the pathogenesis of emphysema is still conjectural and it remains to be proved whether this deficiency is causally related to the development of emphysema or merely acts as a genetic marker. It is possible that a1 antitrypsin normally protects alveolar septa against enzymatic digestion. Gross et al. (1965) showed that in rats panacinar emphysema could be produced by intratracheal instillation of the proteolytic enzyme papain and this has recently been confirmed in dogs (Pushpakom et al., 1970) . The a1 globulins inhibit not only trypsin but also chymotrypsin, plasmin, thrombin and elastase (Rimon, Shamash, and Shapiro, 1966; Turino et al., 1969) . Kueppers and Bearns (1966) 
